{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:39:28Z","timestamp":1759412368261,"version":"3.44.0"},"reference-count":34,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Frontline Gastroenterol"],"accepted":{"date-parts":[[2018,7,9]]},"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:p>Autoimmune hepatitis (AIH) is a rare heterogenous immune-mediated liver disease that for the majority has effective therapy, usually resulting in excellent prognosis. Treatment is based on immunosuppression using standard therapy with corticosteroids and azathioprine. Second-line therapeutic options exist for those who are non-responders (\u2018difficult to treat AIH\u2019) or intolerant to standard therapy; however, their use is not standardised, and in addition, there is vast variation in practice and efficacy. Given the rarity of AIH, expertise in its management can be limited to large referral programmes. In this case-based review, we aim to discuss common clinical dilemmas encountered by clinicians managing adult patients with AIH and address the related competencies in the 2010 Gastroenterology curriculum.<\/jats:p>","DOI":"10.1136\/flgastro-2018-101015","type":"journal-article","created":{"date-parts":[[2018,8,12]],"date-time":"2018-08-12T12:15:29Z","timestamp":1534076129000},"page":"77-87","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Autoimmune hepatitis and complexities in management"],"prefix":"10.1136","volume":"10","author":[{"given":"Ashnila","family":"Janmohamed","sequence":"first","affiliation":[{"name":"Centre for Liver Research, NIHR Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK"},{"name":"University Hospitals Birmingham NHS Foundation Trust Birmingham UK, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gideon M","family":"Hirschfield","sequence":"additional","affiliation":[{"name":"Centre for Liver Research, NIHR Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK"},{"name":"University Hospitals Birmingham NHS Foundation Trust Birmingham UK, Birmingham, UK"},{"name":"Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK"},{"name":"Toronto Centre for Liver Disease, University Health Network, University of Toronto, Toronto, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,8,12]]},"reference":[{"key":"2025090709363268000_10.1.77.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.06.030"},{"key":"2025090709363268000_10.1.77.2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2013.08.001","article-title":"Clinical significance of autoantibodies in autoimmune hepatitis","volume":"46","author":"Liberal","year":"2013","journal-title":"J Autoimmun"},{"key":"2025090709363268000_10.1.77.3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5009\/gnl15352","article-title":"Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions","volume":"10","author":"Czaja","year":"2016","journal-title":"Gut Liver"},{"key":"2025090709363268000_10.1.77.4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22322"},{"key":"2025090709363268000_10.1.77.5","doi-asserted-by":"crossref","first-page":"772","DOI":"10.5604\/01.3001.0010.2787","article-title":"Validation of the Simplified Criteria for the Diagnosis of Autoimmune Hepatitis in Chilean-Hispanic Patients","volume":"16","author":"Candia","year":"2017","journal-title":"Ann Hepatol"},{"key":"2025090709363268000_10.1.77.6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280203"},{"key":"2025090709363268000_10.1.77.7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23584"},{"key":"2025090709363268000_10.1.77.8","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.235259"},{"key":"2025090709363268000_10.1.77.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01904.x"},{"key":"2025090709363268000_10.1.77.10","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200207000-00016"},{"key":"2025090709363268000_10.1.77.11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatology"},{"key":"2025090709363268000_10.1.77.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.12.012"},{"key":"2025090709363268000_10.1.77.13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23840"},{"key":"2025090709363268000_10.1.77.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.01.037"},{"key":"2025090709363268000_10.1.77.15","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840080414"},{"key":"2025090709363268000_10.1.77.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199510123331502"},{"key":"2025090709363268000_10.1.77.17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25760"},{"key":"2025090709363268000_10.1.77.18","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e318154af74"},{"key":"2025090709363268000_10.1.77.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.09.009"},{"key":"2025090709363268000_10.1.77.20","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.06.046"},{"key":"2025090709363268000_10.1.77.21","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.0010000001"},{"key":"2025090709363268000_10.1.77.22","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(92)90178-R"},{"key":"2025090709363268000_10.1.77.23","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.cgh.2017.06.001","article-title":"Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis","volume":"15","author":"Efe","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090709363268000_10.1.77.24","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cgh.2017.09.063","article-title":"Efficacy and Safety of Mycophenolate Mofetil in Patients With\u00a0Autoimmune Hepatitis and Suboptimal Outcomes After\u00a0Standard Therapy","volume":"16","author":"Roberts","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090709363268000_10.1.77.25","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/apt.13584","article-title":"A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis","volume":"43","author":"Zachou","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090709363268000_10.1.77.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.12.032"},{"key":"2025090709363268000_10.1.77.27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/00365521.2015.1095351","article-title":"Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy","volume":"51","author":"Than","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"2025090709363268000_10.1.77.28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04749.x"},{"key":"2025090709363268000_10.1.77.29","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.3748\/wjg.v13.i23.3232","article-title":"Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis","volume":"13","author":"Larsen","year":"2007","journal-title":"World J Gastroenterol"},{"key":"2025090709363268000_10.1.77.30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/2013\/512624","article-title":"Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy","volume":"27","author":"Burak","year":"2013","journal-title":"Can J Gastroenterol"},{"key":"2025090709363268000_10.1.77.31","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21036"},{"key":"2025090709363268000_10.1.77.32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejim.2017.10.006","article-title":"Serology in autoimmune hepatitis: A clinical-practice approach","volume":"48","author":"Terziroli Beretta-Piccoli","year":"2018","journal-title":"Eur J Intern Med"},{"key":"2025090709363268000_10.1.77.33","doi-asserted-by":"publisher","DOI":"10.1111\/his.12558"},{"key":"2025090709363268000_10.1.77.34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jhep.2016.05.023","article-title":"Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis","volume":"65","author":"Hartl","year":"2016","journal-title":"J Hepatol"}],"container-title":["Frontline Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/flgastro-2018-101015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T16:36:39Z","timestamp":1757262999000},"score":1,"resource":{"primary":{"URL":"https:\/\/fg.bmj.com\/lookup\/doi\/10.1136\/flgastro-2018-101015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,12]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12,7]]},"published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.1136\/flgastro-2018-101015"],"URL":"https:\/\/doi.org\/10.1136\/flgastro-2018-101015","relation":{},"ISSN":["2041-4137","2041-4145"],"issn-type":[{"type":"print","value":"2041-4137"},{"type":"electronic","value":"2041-4145"}],"subject":[],"published":{"date-parts":[[2018,8,12]]}}}